Healthcare Industry News:  PEEK 

Devices Orthopaedic Distribution

 News Release - September 6, 2007

Creaspine SAS and SpineSource, Inc. sign US Distribution Agreement

Saint-Louis, Missouri-based SpineSource, Inc. has been granted exclusive rights for the distribution of a novel PEEK (PolyEtherEtherKetone) implant for the whole of the US territory to be launched in the 4th quarter of 2007

Bordeaux, September 6--(HSMN NewsFeed)--Bordeaux-based Creaspine SAS, a research and innovation start-up and manufacturer of spinal implant devices, has entered into an exclusive Distribution Agreement with SpineSource, Inc.

"When evaluating the opportunity with Creaspine, it fulfilled all of the requirements we look for in collaboration: good people, with a good product, which is good for the patient. I am looking forward to providing the American spine surgeons and their patients with what we feel is a superior implant system," said Tom Mitchell, President and CEO of SpineSource.

“This contract is a great leap forward for us” said Franck Tricot, Director of Business Development. “SpineSource’s first class track record on sales performance, product penetration and territory coverage represents a unique opportunity”.

“Tom worked with us to establish a strategic partnership in further reaching out to this key market. We will mutually benefit from their unequalled service to our surgeons end users” added Philippe Jenny, MD, President and CEO.

For information on Creaspine SAS please contact Franck Tricot on franck.tricot@creaspine.com or at +33 681 435 982, or visit Creaspine’s website at www.creaspine.com.

For information on SpineSource, Inc. please contact Tom Mitchell on tmitchell@spinesource.net or at +1 636 536 3700, or visit SpineSource’s website at www.spinesource.net.


Source: Creaspine

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.



FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.